Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 5,787 | 6,469 | 6,495 | 8,234 | 5,326 |
| Operating Income | -5,787 | -6,469 | -6,495 | -8,234 | -5,326 |
| Other Income | 555 | 1,358 | 3,658 | 842 | -174 |
| Pre-tax Income | -5,233 | -5,111 | -2,837 | -7,392 | -5,500 |
| Income Tax | 69 | N/A | 32 | 5 | 35 |
| Net Income Continuous | -5,302 | -5,111 | -2,869 | -7,397 | -5,535 |
| Net Income | $-5,302 | $-5,111 | $-2,869 | $-7,397 | $-5,535 |
| EPS Basic Total Ops | -0.07 | -0.07 | -0.03 | -0.11 | -0.09 |
| EPS Basic Continuous Ops | -0.07 | -0.07 | -0.04 | -0.11 | -0.09 |
| EPS Diluted Total Ops | -0.07 | -0.07 | -0.03 | -0.11 | -0.09 |
| EPS Diluted Continuous Ops | -0.07 | -0.07 | -0.04 | -0.11 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.07 | -0.07 | -0.04 | N/A | N/A |
| EBITDA(a) | $-5,717 | $-6,377 | $-6,417 | $-8,157 | $-5,254 |